MagnetisMM-32
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab Versus Commonly Used Combination Regimens in Participants with Relapsed/Refractory Multiple Myeloma
Filters
Save & Share
Clear Filters
Location
Explore options near your patient - or anywhere in the US.
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sort by
University of Colorado Health - Harmony
Fort Collins, CO
- Accepting patients
Beverly Hills Cancer Center
Beverly Hills, CA
- Accepting patients
- Not yet accepting
Houston Methodist Hospital
Houston, TX
- Not yet accepting
Boca Raton Clinical Research (BRCR) Medical Center
Plantation, FL
- Accepting patients
Nebraska Hematology Oncology
Lincoln, NE
- Accepting patients
Alliance for Multi-Specialty Research
Kansas City, MO
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.